SULLIVAN LOUIS W

EBS

SULLIVAN LOUIS W serves as Director at Emergent BioSolutions Inc. (EBS). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

1 trades

$192.1K

Net Position

Net Seller

$192.1K

Companies Traded

EBS

Active Period

May 2021

1 total trades

Most Recent

Sell EBS

May 10, 2021 · $192.1K

SULLIVAN LOUIS W's Insider Trading at Emergent BioSolutions Inc. (EBS)

Buys

0 · $0.00

Sells

1 · $192.1K

Total Shares Bought

Total Shares Sold

3,118

EBS Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
May 10, 2021↗	Sell	3,118	$61.62	$192.1K	0

Related Insiders

Jessica Perl

SVP, General Counsel, Corp Sec

EBSSell · Feb 9, 2026

Coleen Glessner

EVP, Quality & Ethics, and CPL

EBSSell · Feb 6, 2026

William Hartzel

SVP, Bioservices

EBSSell · Feb 6, 2026

Paul Anthony Williams

SVP, Products Business

EBSSell · Feb 6, 2026

LINDAHL RICHARD S

EVP, Chief Financial Officer

EBSSell · Feb 6, 2026

Simon C Lowry

SVP, R&D, CMO

EBSSell · Dec 14, 2025

Ronald Richard

Director

EBSSell · Dec 5, 2025

Donald W DeGolyer

Director

EBSSell · Nov 10, 2025

Explore More Insider Trading Data

EBS Insider Trading Activity

View all insider trades at Emergent BioSolutions Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity